Multiple sclerosis: current knowledge and future outlook

CP Kamm, BM Uitdehaag, CH Polman - European neurology, 2014 - karger.com
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (…
factors plays a critical role, with childhood and adolescence being the most critical time frames. …

'No evidence of disease activity'–is it an appropriate surrogate in multiple sclerosis?

H Hegen, G Bsteh, T Berger - European journal of neurology, 2018 - Wiley Online Library
… treatments available for multiple sclerosis has broadened … in the management of multiple
sclerosis patients. The concept of ‘… Here, existing literature on NEDA is critically reviewed and …

The cerebrospinal fluid in multiple sclerosis: far beyond the bands

RB Domingues, GBP Fernandes, FBVM Leite… - Einstein (Sao …, 2017 - SciELO Brasil
… drugs for multiple sclerosis treatment in recent years. In this review, we critically evaluate the
… The aim of this study is to critically review the existing literature on the new CSF biomarkers …

Exercise in patients with multiple sclerosis

RW Motl, BM Sandroff, G Kwakkel, U Dalgas… - The lancet …, 2017 - thelancet.com
… strategy for people with multiple sclerosis to manage symptoms… of exercise in people with
multiple sclerosis, and the absence … in multiple sclerosis based on a meta-analysis and critical

[HTML][HTML] Is there any relation between chronic cerebrospinal venous insufficiency and multiple sclerosis?–a critical review

W Jedynak, A Cieszanowski - Polish Journal of Radiology, 2014 - ncbi.nlm.nih.gov
… Though the etiology of multiple sclerosis remains unknown, … of the pathogenesis of multiple
sclerosis, proposing the new … treatment for multiple sclerosis involving venoplasty of the …

COVID-19 severity among patients with multiple sclerosis treated with cladribine: a systematic review and meta-analysis

A Albanese, MP Sormani, G Gattorno… - Multiple Sclerosis and …, 2022 - Elsevier
… extracting original articles on COVID-19 and multiple sclerosis. The key inclusion criteria were
the … version of the Dutch Cochrane center critical review checklist proposed by MOOSE. A …

Disease-modifying agents for multiple sclerosis: recent advances and future prospects

T Menge, MS Weber, B Hemmer, BC Kieseier… - Drugs, 2008 - Springer
… These are critically reviewed and put into perspective. … Multiple sclerosis (MS) is a chronic
disease confined to the CNS. … of the following keywords: multiple sclerosis OR experimental …

Anti-CD20 B cell treatment for relapsing multiple sclerosis

CA Roach, AH Cross - Frontiers in neurology, 2021 - frontiersin.org
… targeting B cells in the treatment of relapsing multiple sclerosis (MS). More modest efficacy
… In this mini review, we will critically review previous and ongoing clinical trials of anti-CD20 …

Cerebrospinal fluid markers in multiple sclerosis: an overview

AR Massaro, P Tonali - Multiple Sclerosis Journal, 1998 - journals.sagepub.com
… Therefore, the possible use of CSF MBP, S-100, GFAP, N-CAM, NGF, and CNTF in pathogenetic
studies and in clinical follow-up is critically reviewed. The need for correct interpretation …

Which immune cells matter? The immunopathogenesis of multiple sclerosis

B Broux, P Stinissen, N Hellings - Critical Reviews™ in …, 2013 - dl.begellhouse.com
Multiple sclerosis (MS) is a complex disease of the central nervous system (CNS), which is
believed to be immune-mediated. While CD4+ T cells have been the main suspects for years, …